Delivery Order SPE2DB25D3109-SPE2DB25FPKXM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,774.79 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication. This firm fixed price, non-set-aside contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement to support...
- The Defense Logistics Agency awarded a delivery order valued at $3,143.07 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Norditropin is a human growth hormone therapeutic used in medical treatment, and this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,354.52 to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 mL, a human growth hormone medication. The award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same jurisdiction. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,261.67 to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 mL, a human growth hormone medication. This non-set-aside, firm fixed-price delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.84 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a routine pharmaceutical procurement under the company's broader relationship with DLA. The contract was competitively awarded with no set-aside designation and will be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,917.35 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone therapeutic product. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 ml, a human growth hormone medication, valued at $5,005.52 with a firm fixed price structure. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,793.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml pharmaceutical supplies, with an ultimate completion date of July 1, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion ceiling through December 2026. The products will be delivered to the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,341.38 to AmerisourceBergen Drug Corp for Norditropin Flexpro 15 mg/1.5 mL pharmaceutical supplies. This firm fixed-price, non-set-aside contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Norditropin Flexpro is a human growth hormone therapeutic used to treat growth hormone...
- The Defense Logistics Agency awarded a delivery order valued at $1,164.10 to AmerisourceBergen Drug Corp for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This firm fixed price contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, was competitively awarded with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order is issued under...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB25FPKXMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,688.10 to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 ml pharmaceutical supplies. This firm fixed-price, non-set-aside contract was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Norditropin is a human growth hormone therapeutic used to treat growth disorders and other endocrine conditions, making this a specialized pharmaceutical procurement supporting federal healthcare requirements. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and a prime vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications, vaccines, and medical supplies to support military healthcare systems and the Defense Health Agency. The parent IDC vehicle enables the company to efficiently fulfill federal pharmaceutical needs across multiple therapeutic domains on a global basis, with this particular delivery order representing a routine replenishment of specialty pharmaceutical inventory.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/6/25 |